Life Science Nation (LSN) was founded by Dennis Ford, CEO, in 2012 to bring a better sales and marketing awareness to the life science community.
LSN's goal is to educate scientists in the basic skills required to brand, message, and market their companies.
Before LSN, Dennis was the CEO of a company that pioneered a system for uncovering global institutional investors and gauging their appetite regarding investing in hedge funds, private equity funds, and venture capital (VC) funds.
The methodology used to capture and curate this valuable data was developed in part by a research team that would cold call and canvass these investors.
The team would conduct a one-on-one interview with each investor that uncovered any current investment mandates they had.
This allowed them to identify exactly where the capital was and specifically who had the mandate to deploy it.
After working with fundraisers in the alternative finance space for six years, Dennis wanted to bring his expertise to the life sciences and channel this fundraising experience toward the goal of moving science forward.
knew from his
experience in the alternatives field that many institutional investors and family offices were starting to withdraw capital from funds due to a decade of sub-par returns, initiating a trend of direct investment.
sought to create a match.com-like sourcing platform for the life sciences.
knew that he
needed not only current, accurate, and actionable information on both of the constituent groups who would use the platform, but also a home for the data he
had started to gather on early stage life science investors.
Launching Life Science Nation
needed to find a database to house the investor data he
had begun to curate and he
needed to find a source of data on global early stage biotech and medtech companies.
spent six months searching the world for an existing, comprehensive life sciences company database based on a reliable architecture with a well-designed search ontology that facilitated quick easy search and ease of navigation based on the needs of users in the life science sector.
Dennis uncovered a strategic partner that fit these criteria in Venture Valuation (VV), owner of the Biotechgate database, in Zurich, Switzerland.
could add some significant value by helping to commercialize their platform in North America.
vision to the founders of Venture Valuation
and formed a strategic alliance, whereby LSN
would use the existing database in order to rapidly develop and house its LSN Investor Platform and resell the Biotechgate database.
Word got out that Dennis
was spinning up LSN
, and interested entrepreneurs began to inquire about the new entity.
Dennis forged a relationship with the UMass Boston where he teaches an Entrepreneurship and Sales course and with the UMass Venture Development Center.